Showing 1 - 10 of 26,752
Persistent link: https://www.econbiz.de/10001294370
Multinational pharmaceutical corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These...
Persistent link: https://www.econbiz.de/10014047447
Persistent link: https://www.econbiz.de/10009675482
Persistent link: https://www.econbiz.de/10008856196
Persistent link: https://www.econbiz.de/10011453911
1. Pharmaceutical industry structure and its effect on marketing performance and product innovation -- 2. The environmental forces that influence industry stakeholders and shape their interactions -- 3. Global health care systems and market access : variations on a theme -- 4. The structure of...
Persistent link: https://www.econbiz.de/10013181948
Prompt and affordable access to essential medicines is a component of almost all domestic and global public health models. As is now well known, the availability and costs of both brand and generic drugs is a function of traditional patent law incentives. Less known, however, is that generic...
Persistent link: https://www.econbiz.de/10014189151
Persistent link: https://www.econbiz.de/10000925959
Persistent link: https://www.econbiz.de/10011326670
Persistent link: https://www.econbiz.de/10011740003